CollPlant Biotechnologies Ltd. (CLGN)
0.3203
-0.02
(-6.70%)
USD |
NASDAQ |
Sep 03, 16:00
0.33
+0.01
(+3.03%)
After-Hours: 20:00
CollPlant Biotechnologies Total Liabilities (Quarterly) : 4.297M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 4.297M |
| December 31, 2025 | 4.704M |
| September 30, 2025 | 4.784M |
| June 30, 2025 | 4.932M |
| March 31, 2025 | 4.811M |
| December 31, 2024 | 5.245M |
| September 30, 2024 | 5.524M |
| June 30, 2024 | 5.837M |
| March 31, 2024 | 5.846M |
| December 31, 2023 | 5.786M |
| September 30, 2023 | 5.16M |
| June 30, 2023 | 5.53M |
| March 31, 2023 | 5.869M |
| December 31, 2022 | 5.487M |
| September 30, 2022 | 4.752M |
| June 30, 2022 | 4.908M |
| March 31, 2022 | 5.527M |
| December 31, 2021 | 6.103M |
| September 30, 2021 | 5.154M |
| June 30, 2021 | 5.582M |
| March 31, 2021 | 5.985M |
| December 31, 2020 | 6.364M |
| September 30, 2020 | 5.901M |
| June 30, 2020 | 5.171M |
| March 31, 2020 |
| Date | Value |
|---|---|
| December 31, 2019 | |
| September 30, 2019 | 14.09M |
| June 30, 2019 | 7.523M |
| March 31, 2019 | 8.216M |
| December 31, 2018 | 4.006M |
| September 30, 2018 | 2.173M |
| June 30, 2018 | 2.409M |
| March 31, 2018 | 1.701M |
| December 31, 2017 | 5.115M |
| September 30, 2017 | 3.230M |
| June 30, 2017 | 1.185M |
| March 31, 2017 | 1.369M |
| December 31, 2016 | 1.843M |
| September 30, 2016 | 1.322M |
| June 30, 2016 | 1.096M |
| March 31, 2016 | 0.9541M |
| December 31, 2015 | 0.9638M |
| September 30, 2015 | 0.8454M |
| June 30, 2015 | 0.6768M |
| March 31, 2015 | 0.7222M |
| December 31, 2014 | 0.6802M |
| September 30, 2014 | 0.6061M |
| June 30, 2014 | 0.6061M |
| March 31, 2014 | 0.6656M |
| December 31, 2013 | 0.9188M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 46.19M |
| Perspective Therapeutics, Inc. | 68.16M |
| MiMedx Group, Inc. | 65.00M |
| Regentis Biomaterials Ltd. | -- |
| Xylo Technologies Ltd. | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.183M |
| Shareholders Equity (Quarterly) | 4.886M |
| Debt to Equity Ratio | 0.5422 |
| Current Ratio | 2.268 |
| Net Debt Paydown Yield | 1.12% |